2021, Number 11
<< Back Next >>
Ginecol Obstet Mex 2021; 89 (11)
Miomectomy during pregnancy: giant leiomyoma with degeneration
Rivera-Coyotzi E, Castañeda-Díaz M, Martínez-Salazar GJ, de la O-Pérez LO, Zamora-Andrade HR, García-Estudillo FO
Language: Spanish
References: 13
Page: 898-904
PDF size: 262.12 Kb.
ABSTRACT
Background: Leiomyomas are the most common pelvic tumors, with multiple
clinical presentations throughout a woman's life. It is unusual for them to appear during
pregnancy and to merit surgical treatment, especially for acute abdomen secondary
to degeneration.
Objective: To provide and expose the process of diagnosis, surgical treatment and
obstetric outcome in a patient with a giant leiomyoma with pregnancy-associated
degeneration.
Clinical case: A 34-year-old primigravida patient, 22.1 weeks pregnant. She came
to the emergency department with acute abdomen, fever and ventilatory impairment
secondary to a giant leiomyoma that occupied the entire abdomen and compressed
abdominal and thoracic structures. Due to the clinical deterioration, surgery was decided
to remove the two fibroids: the larger one measuring 35 x 20 cm and weighing
9150 g. The postoperative evolution was favorable. The postoperative evolution was
favorable as well as the prenatal control. The pregnancy was terminated by elective
cesarean section at 38.1 weeks, without maternal or perinatal complications.
Conclusion: Myomectomy during pregnancy is a safe procedure to reduce maternal
and fetal morbidity and mortality in selected cases.
REFERENCES
McWilliams MM, Chennathukuzhi VM. Recent Advances in Uterine Fibroid Etiology. Semin Reprod Med 2017; 35 (2): 181-89. doi:10.1055/s-0037-1599090
Baird D, Dunson D, Hill MC, Cousins C, et al. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol 2003; 188 (1): 100-7. doi:10.1067/mob.2003.99
Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997; 90 (6): 967-73. doi: 10.1016/s0029-7844(97)00534-6
Marsh EE, Ekpo GE, Cardozo ER, Brocks M, et al. Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18-30 years old): a pilot study. Fertil Steril 2013; 99 (7): 1951-57. doi: 10.1016/j. fertnstert.2013.02.017
Stout MJ, Odibo AO, Graseck AS, Macones GA, et al. Leiomyomas at routine second-trimester ultrasound examination and adverse obstetric outcomes. Obstet Gynecol 2010; 116 (5): 1056-63. doi:10.1097/aog.0b013e3181f7496d
Morgan-Ortiz F, Piña-Romero B, Elorriaga-García E, Báez- Barraza J, et al. Miomas uterinos durante el embarazo y su repercusión en el resultado obstétrico. Ginecol Obstet Mex 2011; 79 (8): 467-73.
Burton CA, Grimes DA, March CM. Surgical management of leiomyomata during pregnancy. Obstet Gynecol 1989; 74 (5): 707-9.
Benaglia L, Cardellicchio L, Filippi F, Paffoni A, et al. The rapid growth of fibroids during early pregnancy. Más Uno 2014; 9 (1): e85933. doi: 10.1371/journal.pone.0085933
Mollica G, Pittini L, Minganti E, Perry G, et al. Elective uterine myomectomy in pregnant women. Clin Exp Obstet Gynecol 1996; 23 (3): 168-72. PMID: 8894327.
Dueholm M, Lundorf E, Hansen ES, Ledertoug S, et al. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol 2002; 186 (3): 409-15. doi:10.1067/mob.2002.121725
Munro MG, Critchley HO, Fraser IS. FIGO Menstrual Disorders Working Group, The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril 2011; 95 (7): 2204-08.e22083. doi:10.1016/j.fertnstert. 2011.03.079
Faulkner RL. Red degeneration of uterine myomas. Am J Obstet Gynecol 1947; 53 (3): 474-82. doi:10.1016/0002- 9378(47)90410-9
De Carolis S, Fatigante G, Ferrazzani S, Tribellini C, et al. Uterine myomectomy in pregnant women. Fetal Diagn Ther 2001; 16: 116-119. doi: 10.1159/000053893
Full text